Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion type Assertion NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_head.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion description "[The increasing resistance of falciparum malaria to common antimalarial drugs has renewed interest in the compound proguanil normally metabolized to cycloguanil, a strong dihydrofolate reductase inhibitor, via the cytochrome P450 isozyme CYP2C19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_provenance.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion evidence source_evidence_literature NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_provenance.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion SIO_000772 10471063 NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_provenance.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion wasDerivedFrom befree-2016 NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_provenance.
- NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_assertion wasGeneratedBy ECO_0000203 NP261974.RAhQ8qSVnFG6dJcXTBC--zec-YV30BejuuA_x8H7ZhGTY130_provenance.